FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014261949> ?p ?o ?g. }

• W3014261949 endingPage "2120" @default.
• W3014261949 startingPage "2112" @default.
• W3014261949 abstract "Abstract Background Multidrug-resistant (MDR) bacteria are frequently defined using the criteria established by Magiorakos et al [Clin Microbiol Infect 2012;18:268–81]. Difficult-to-treat resistance (DTR) [Kadri et al, Clin Infect Dis 2018;67:1803–14] is a novel approach to defining resistance in gram-negative bacilli focusing on treatment-limiting resistance to first-line agents (all β-lactams and fluoroquinolones). Methods Clinical and Laboratory Standards Institute–defined broth microdilution minimum inhibitory concentrations (MICs) were determined for imipenem/relebactam, ceftolozane/tazobactam, and comparators against respiratory, intraabdominal, and urinary isolates of Enterobacterales (n = 10 516) and Pseudomonas aeruginosa (n = 2732) collected in 26 US hospitals in 2015–2017. Results Among all Enterobacterales, 1.0% of isolates were DTR and 15.6% were MDR; 8.4% of P. aeruginosa isolates were DTR and 32.4% were MDR. MDR rates for Enterobacterales and DTR and MDR rates for P. aeruginosa were significantly higher (P &lt; .05) in isolates collected in intensive care units (ICUs) than in non-ICUs and in respiratory tract isolates than in intraabdominal or urinary tract isolates. In addition, 82.4% of DTR and 92.1% of MDR Enterobacterales and 62.2% of DTR and 82.2% of MDR P. aeruginosa were imipenem/relebactam-susceptible, and 1.5% of DTR and 65.8% of MDR Enterobacterales and 67.5% of DTR and 84.0% of MDR P. aeruginosa were ceftolozane/tazobactam-susceptible. Conclusions MDR phenotypes defined using the Magiorakos criteria may overcall treatment-limiting resistance in gram-negative bacilli. In the US, DTR Enterobacterales were infrequent, while MDR Enterobacterales isolates and DTR and MDR P. aeruginosa were common. Imipenem/relebactam (Enterobacterales, P. aeruginosa) and ceftolozane/tazobactam (P. aeruginosa) retained in vitro activity against most DTR and MDR isolates." @default.
• W3014261949 created "2020-04-10" @default.
• W3014261949 creator A5017159626 @default.
• W3014261949 creator A5038009031 @default.
• W3014261949 creator A5042149117 @default.
• W3014261949 creator A5046963464 @default.
• W3014261949 creator A5051610461 @default.
• W3014261949 creator A5061522332 @default.
• W3014261949 creator A5089366807 @default.
• W3014261949 date "2020-04-03" @default.
• W3014261949 modified "2023-10-16" @default.
• W3014261949 title "In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes—Study for Monitoring Antimicrobial Resistance Trends, United States 2015–2017" @default.
• W3014261949 cites W2030281331 @default.
• W3014261949 cites W2058916766 @default.
• W3014261949 cites W2094812731 @default.
• W3014261949 cites W2112021685 @default.
• W3014261949 cites W2113480160 @default.
• W3014261949 cites W2113957516 @default.
• W3014261949 cites W2142343447 @default.
• W3014261949 cites W2252374742 @default.
• W3014261949 cites W2469832424 @default.
• W3014261949 cites W2615674137 @default.
• W3014261949 cites W2783070039 @default.
• W3014261949 cites W2800004776 @default.
• W3014261949 cites W2902901967 @default.
• W3014261949 cites W2918952258 @default.
• W3014261949 cites W2921444421 @default.
• W3014261949 cites W2943815887 @default.
• W3014261949 cites W2945135952 @default.
• W3014261949 cites W2955048139 @default.
• W3014261949 cites W3003554341 @default.
• W3014261949 doi "https://doi.org/10.1093/cid/ciaa381" @default.
• W3014261949 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32246147" @default.
• W3014261949 hasPublicationYear "2020" @default.
• W3014261949 type Work @default.
• W3014261949 sameAs 3014261949 @default.
• W3014261949 citedByCount "42" @default.
• W3014261949 countsByYear W30142619492020 @default.
• W3014261949 countsByYear W30142619492021 @default.
• W3014261949 countsByYear W30142619492022 @default.
• W3014261949 countsByYear W30142619492023 @default.
• W3014261949 crossrefType "journal-article" @default.
• W3014261949 hasAuthorship W3014261949A5017159626 @default.
• W3014261949 hasAuthorship W3014261949A5038009031 @default.
• W3014261949 hasAuthorship W3014261949A5042149117 @default.
• W3014261949 hasAuthorship W3014261949A5046963464 @default.
• W3014261949 hasAuthorship W3014261949A5051610461 @default.
• W3014261949 hasAuthorship W3014261949A5061522332 @default.
• W3014261949 hasAuthorship W3014261949A5089366807 @default.
• W3014261949 hasBestOaLocation W30142619491 @default.
• W3014261949 hasConcept C114851261 @default.
• W3014261949 hasConcept C133936738 @default.
• W3014261949 hasConcept C176947019 @default.
• W3014261949 hasConcept C2776870249 @default.
• W3014261949 hasConcept C2777637488 @default.
• W3014261949 hasConcept C2778266534 @default.
• W3014261949 hasConcept C2779631663 @default.
• W3014261949 hasConcept C2780950330 @default.
• W3014261949 hasConcept C4937899 @default.
• W3014261949 hasConcept C501593827 @default.
• W3014261949 hasConcept C523546767 @default.
• W3014261949 hasConcept C54355233 @default.
• W3014261949 hasConcept C71924100 @default.
• W3014261949 hasConcept C86803240 @default.
• W3014261949 hasConcept C89423630 @default.
• W3014261949 hasConcept C94665300 @default.
• W3014261949 hasConceptScore W3014261949C114851261 @default.
• W3014261949 hasConceptScore W3014261949C133936738 @default.
• W3014261949 hasConceptScore W3014261949C176947019 @default.
• W3014261949 hasConceptScore W3014261949C2776870249 @default.
• W3014261949 hasConceptScore W3014261949C2777637488 @default.
• W3014261949 hasConceptScore W3014261949C2778266534 @default.
• W3014261949 hasConceptScore W3014261949C2779631663 @default.
• W3014261949 hasConceptScore W3014261949C2780950330 @default.
• W3014261949 hasConceptScore W3014261949C4937899 @default.
• W3014261949 hasConceptScore W3014261949C501593827 @default.
• W3014261949 hasConceptScore W3014261949C523546767 @default.
• W3014261949 hasConceptScore W3014261949C54355233 @default.
• W3014261949 hasConceptScore W3014261949C71924100 @default.
• W3014261949 hasConceptScore W3014261949C86803240 @default.
• W3014261949 hasConceptScore W3014261949C89423630 @default.
• W3014261949 hasConceptScore W3014261949C94665300 @default.
• W3014261949 hasFunder F4320332932 @default.
• W3014261949 hasIssue "12" @default.
• W3014261949 hasLocation W30142619491 @default.
• W3014261949 hasOpenAccess W3014261949 @default.
• W3014261949 hasPrimaryLocation W30142619491 @default.
• W3014261949 hasRelatedWork W2055786907 @default.
• W3014261949 hasRelatedWork W2151828834 @default.
• W3014261949 hasRelatedWork W2163881342 @default.
• W3014261949 hasRelatedWork W2350985886 @default.
• W3014261949 hasRelatedWork W2361473255 @default.
• W3014261949 hasRelatedWork W2386257037 @default.
• W3014261949 hasRelatedWork W2753184995 @default.
• W3014261949 hasRelatedWork W2978003125 @default.
• W3014261949 hasRelatedWork W3097647920 @default.
• W3014261949 hasRelatedWork W2998907924 @default.
• W3014261949 hasVolume "72" @default.

• next